Advancing Ophthalmology Trademark Details
Word Mark | Advancing Ophthalmology |
---|---|
Status | Dead 602 — Abandoned-Failure to Respond or Late Response |
Current Owner
Medtronic Xomed, Inc. of Jacksonville, FL
View all trademarks for Medtronic Xomed, Inc.Serial Number | 78414798 |
---|---|
Status Date | Tuesday, August 1, 2006 |
Filing Date | Tuesday, August 1, 2006 |
Attorney | Thomas G. Berry |
Correspondent
Trademark Dept.
Medtronic, Inc.
LC 340
710 Medtronic Parkway
Minneapolis, MN 55432-5604
Medtronic, Inc.
LC 340
710 Medtronic Parkway
Minneapolis, MN 55432-5604
Case File Statements
Disclaimer with Predetermined Text | "Ophthalmology" |
---|---|
Goods & Services | Printed Materials, Namely, Pamphlets, Bulletins, Brochures, Manuals and Journals in the Field of Eye Care and Ophthalmology |
Classifications
International Class Codes |
016
|
---|---|
U.S. Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
Status | 6 — Active |
Status Date | Friday, May 14, 2004 |
First Use Anywhere | Friday, July 1, 2005 |
First Use In Commerce | Friday, July 1, 2005 |
Primary Code | 016 |
Trademark Timeline
-
May 07 2004Trademark application filed with USPTO
-
May 14 2004New Application Entered In Tram
-
Dec 07 2004Assigned To Examiner
-
Dec 08 2004Examiner's Amendment Mailed
-
Dec 08 2004Approved For Pub - Principal Register
-
Dec 08 2004Examiners Amendment -Written
-
Dec 10 2004Assigned To Lie
-
Jan 06 2005Law Office Publication Review Completed
-
Mar 16 2005Notice of Publication
-
Apr 05 2005Published For Opposition
-
Jun 28 2005Noa Mailed - Sou Required From Applicant
-
Jul 01 2005First use anywhere for the mark
-
Jul 01 2005First use in commerce for the mark
-
Oct 31 2005Use Amendment Filed
-
Oct 31 2005Teas Statement of Use Received
-
Nov 15 2005Statement of Use Processing Complete
-
Dec 29 2005Su - Non-Final Action - Written
-
Dec 29 2005Non-Final Action Mailed
-
Dec 30 2005Non-Final Action Mailed
-
Aug 01 2006Abandonment Notice Mailed - Failure To Respond
-
Aug 01 2006Abandonment - Failure To Respond Or Late Response